Communicating Our Science to Our Customers:Drug Discovery in Five Simple Experiments by Pearson, Lesley-Anne & Foley, David William
                                                              
University of Dundee
Communicating Our Science to Our Customers
Pearson, Lesley-Anne; Foley, David William
Published in:
ACS Medicinal Chemistry Letters
DOI:
10.1021/acsmedchemlett.7b00015
Publication date:
2017
Document Version
Peer reviewed version
Link to publication in Discovery Research Portal
Citation for published version (APA):
Pearson, L-A., & Foley, D. W. (2017). Communicating Our Science to Our Customers: Drug Discovery in Five
Simple Experiments. ACS Medicinal Chemistry Letters, 8(2), 143-144.
https://doi.org/10.1021/acsmedchemlett.7b00015
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 05. Apr. 2019
 Communicating Our Science to Our Customers: Drug Discov-
ery in Five Simple Experiments 
Lesley-Anne Pearson and David William Foley* 
Drug Discovery Unit, School of Life Sciences, University of Dundee, Dundee, DD1 4EH, UK. 
ABSTRACT: The complexities of modern drug discovery – an interdisciplinary process that often takes years and costs billions – 
can be extremely challenging to explain to a public audience. We present details of a 30 minute demonstrative lecture that uses well 
known experiments to illustrate key concepts in drug discovery including synthesis, assay and metabolism. 
A recent viewpoint1 in this journal issued a call to arms for 
scientists, especially those working in drug discovery, to engage 
with the wider community: extoling us to fill the gaps in 
knowledge that leave room for misinformation and doubt, and 
to take seriously the concerns and questions of our ultimate cus-
tomers. This is a call that we feel passionately about. We too 
believe that ‘open sharing’ of science cannot stop with our sci-
entific peers, but must include those with whom we do not share 
a common technical language.  
Our colleagues highlighted previously the contributions 
made by our cyberspace advocates, who use blogs and forums 
to debate, inform and defend the public from some of the more 
spurious pseudo-scientific claims and conspiracies. But what of 
real world public engagement? As stated in the previous View-
point and evidenced by the recent RSC report on Public Atti-
tudes to Chemistry,2 the public at large are not anti-science per 
se and are in fact keen to understand the fundamental process 
that govern the world around us. Their desire to engage with 
and understand science is also supported by the myriad of suc-
cessful science festivals held around the world. Whilst these 
events are typically aimed at enthusing the public about science 
generally, surely the exciting world of drug discovery has a 
place at these real world events, in addition to our virtual pres-
ence? 
Drug discovery is a lengthy, complex and expensive task with 
a high failure rate. Equally, outreach can be seen by many as a 
time-consuming, complex task that delivers little in return. 
Small biotechs in particular may struggle to justify spending re-
sources in this area, ahead of meeting critical project mile-
stones. However, in the growing sector of academic drug dis-
covery, there are stronger incentives to conduct outreach and 
engagement: from maintaining a strong relationship with their 
local communities to increasing student recruitment. Not only 
that, it is usually a condition of public sector funding. In fact, 
universities are old hands at outreach, and opportunities exist 
for drug discoverers within these institutions to support the Bi-
oPharma industry in this area. 
The challenge of explaining the drug discovery process to a 
general audience can seem daunting. How can we possibly hope 
to condense such a lengthy, iterative and interdisciplinary pro-
cess into a format suitable for presentation to the public? When 
Table 1 An overview of the Drug Discovery in Five Experi-
ments Public Engagement Lecture 
Process Experiment 
What is a disease and what is 
a medicine? 
Malonic acid clock with salt 
quench 
(Iterative) Organic synthesis Aldol reaction of cinnemalde-
hye with acetone in ethanol 
Biochemical Assay Iodine clock experiment at 
two different concentrations 
Physicochemical properties Effect of dry ice on aqueous 
pH and solubility of polysty-
rene in acetone 
Metabolism Elephant’s toothpaste (or io-
dine snake) decomposition of 
hydrogen peroxide using yeast 
as the catalyst 
we understand so little of the biology underlying health and dis-
ease, are we even qualified to “preach” about what we do? At 
the University of Dundee, we have previously delivered major 
outreach activities focussed on our research strengths, including 
Magnificent Microbes and Biofilms: Building Bacterial Cities.3-
4 The DDU therefore set itself the challenge of capturing the 
essence of drug discovery in a 30 minute demonstrative lecture. 
Our idea involved identifying the key concepts and using well-
established experiments to illustrate (Table 1).5 Each experi-
ment was selected to be visually captivating (that ‘wow’ factor), 
but also to be accurately, or at least appropriately, illustrative. 
We may have simplified in the extreme, but we strive to never 
lie or patronize the public. Here we include a brief discussion 
of the experiments for interested readers and are happy to enter 
into correspondence with those who require more information. 
What is a disease/medicine:  This first experiment is key to 
setting the tone of the lecture and adjusting according to the au-
dience. For example, the use of the word “drug” instead of 
“medicine” is ill-advised in some circumstances. The classic os-
cillating oxidation reaction of malonic acid with potassium bro-
mate is used by the biologist to exemplify concepts of cell sig-
naling, both in healthy and diseased states. This allows us to 
 explain the process of target validation in a simplified and vis-
ual manner. Salt (which interrupts the oscillation) takes the 
place of a medicine in our analogy, selectively blocking the sig-
nal and thus “curing” the disease. 
Organic Synthesis: Once the biologist has demonstrated 
how drugs work, the chemist illustrates the process of produc-
ing one. Whilst the medicinal chemist strives to avoid making 
such a classic example of “brick dust” in his daily work, the 
robust condensation reaction of cinnemaldehyde with acetone 
neatly illustrates the concept of synthesis. A Lego brick analogy 
is used: by understanding some basic rules and using some im-
agination, we can create objects with many different shapes and 
properties. Similarly, applying the rules of organic chemistry 
allows a wide variety of molecules with different shapes and 
properties to be synthesized. Here, we begin to introduce the 
concept of multiple property optimization that is required for 
successful drug discovery, which we build upon throughout the 
talk. 
Biochemical Assay: Of course, a key property in any drug 
discovery project is potency. Segueing neatly from the previous 
experiment, the biologist explains to the audience the chal-
lenges of finding out if a molecule we know nothing about can 
inhibit the action of an enzyme that is too small to see! We use 
the classic iodine clock reaction to demonstrate a biochemical 
assay. The reaction is carried out simultaneously at two differ-
ent concentrations, resulting in a temporally staggered color 
change. The audience participates by counting the time until the 
color change. The time difference allows us to discuss how 
these assays enable identification of the most potent molecules 
in a screening or optimization campaign. We have also used 
samples of GFP and UV light as well as the chemiluminescent 
oxidation of luminol by hydrogen peroxide as variations to this 
demonstration. 
Physicochemical properties: A successful drug requires a 
balance of properties beyond potency. A medicine must be sol-
uble, stable to a variety of enzymes and able to cross lipophilic 
membranes. By adding universal indicator to alkaline water and 
acidifying by addition of dry ice, we are able to highlight chang-
ing pH and compare this to the different pHs in the stomach, 
intestine and blood. The chemist demonstrates lipid solubility 
by dissolving a coffee cup with acetone, which allows us to 
highlight the need for successful drugs to be soluble in both 
aqueous and lipid environments. 
Metabolism: Another key property in drug discovery is met-
abolic stability. The biologist uses yeast as a “liver substitute” 
in the catalytic decomposition of concentrated hydrogen perox-
ide. The discussion touches on important topics such as dosing 
schedules, toxicity etc., with food digestion and waste as an 
easy lead into the concept. 
In addition to the specifics of the lecture there are a number 
of broader learnings that can be taken from it. The show is 
highly adaptable, and can accommodate groups of different 
ages and scientific literacy. It can also be performed in a wide 
variety of locations including schools and community centres 
thus offering us the chance to take drug discovery out of the lab 
and into the world. The “flow” of the demonstrations reflects 
the drug discovery cycle and the interplay between the biologist 
and chemist lecturers mirrors this key professional relationship. 
We have found it crucial to allow the individual personalities of 
the lecturers to come to the fore in order to dispel the stereo-
types of a typical scientist. 
Feedback has been overwhelmingly positive and engagement 
is high, with audiences of all ages enjoying the show. After-
wards, they are left with a better understanding of the highs and 
lows of the drug discovery process, and certainly take away key 
messages related to time, teamwork and cost. 
Public outreach is not a chore, but rather an opportunity to 
craft a truly meaningful interaction with those who have the 
most to gain from our work. As drug discovery scientists, we 
have one major advantage when communicating our work to the 
public: they are already familiar with medicines from their bath-
room cabinets. What they are less familiar with are the cost and 
time required for successful drug discovery. The onus is there-
fore on us to communicate these complexities, particularly in 
academia where most our funding comes from the public purse. 
If the public do not understand that it can take 15 years to de-
velop a new drug, then how can they grasp the urgency of fund-
ing research into new antibiotics today? We offer our show to 
the drug discovery community for use and adaptation, to foster 
and encourage more engagement of the public with our science. 
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